Appealing to Americans’ altruism is not enough to nudge them to accept novel vaccines
Journal of Public Health · 25.08.2024 · 46 (3) · e494-e499
DOI: 10.1093/pubmed/fdae048 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Public Health, online erschienen am 03.04.2024. Verfasst von Emmanuel F Drabo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Altruism, COVID-19, COVID-19 Vaccines, Patient Acceptance of Health Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Teresa and Byron Pollitt Family Chair in Fetal & Neonatal Medicine at Children's Hospital Los Angeles, Fetal and Neonatal Institute, Division of Neonatology.
Abstract (Originalsprache)
Background
The role of altruism in the acceptance of novel preventive healthcare technologies like vaccines has not been thoroughly elucidated.
Methods
We 1:1 randomized n = 2004 Amazon Mechanical Turk (MTurk) participants residing in the USA into a control or treatment arm with vaccination decisions framed altruistically, to elicit their preferences for COVID-19 vaccination using web-based discrete choice experiments. We used conditional and mixed logit models to estimate the impact of framing decisions in terms of altruism on vaccination acceptance.
Results
Valid responses were provided by 1674 participants (control, n = 848; treatment, n = 826). Framing vaccination decisions altruistically had no significant effect on vaccination acceptance. Further, respondents’ degree of altruism had no association with vaccination acceptance.
Limitations
The MTurk sample may not be representative of the American population. We were unable to ascertain concordance between stated and revealed preferences. Conclusions and Implications Framing vaccination decisions in terms of altruism does not appear to significantly influence vaccination acceptance and may not be an effective nudging mechanism to increase the uptake of novel vaccines. Instead, a favorable vaccination profile appears to be the primary driver of uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA.
- Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA 90007, USA.
- Division of Neonatology, Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, Fetal and Neonatal Institute, University of Southern California, Los Angeles, CA 90027, USA.
ORCID-Profile: Cynthia L Gong
Förderung
- Teresa and Byron Pollitt Family Chair in Fetal & Neonatal Medicine at Children's Hospital Los Angeles
- Fetal and Neonatal Institute
- Division of Neonatology
- Department of Pediatrics
- Children's Hospital Los Angeles
- Keck School of Medicine
- University of Southern California
- Teresa and Byron Pollitt Family Chair in Fetal & Neonatal Medicine at Children’s Hospital Los Angeles
Zitieren
APA
Drabo, E. F., Kelley, M. A., & Gong, C. L. (2024). Appealing to Americans’ altruism is not enough to nudge them to accept novel vaccines. Journal of Public Health, 46(3), e494-e499. https://doi.org/10.1093/pubmed/fdae048
Vancouver
Drabo EF, Kelley MA, Gong CL. Appealing to Americans’ altruism is not enough to nudge them to accept novel vaccines. Journal of Public Health. 2024;46(3):e494-e499. doi:10.1093/pubmed/fdae048
BibTeX
@article{Drabo2024,
author = {Drabo, Emmanuel F and Kelley, Marcella A and Gong, Cynthia L},
title = {Appealing to Americans’ altruism is not enough to nudge them to accept novel vaccines},
journal = {Journal of Public Health},
year = {2024},
volume = {46},
number = {3},
pages = {e494--e499},
doi = {10.1093/pubmed/fdae048}
}
EUVIMED